Market Tracker

03/28 5:16pm ET

BioLine RX Ltd (NASDAQ:BLRX)

1.17
Delayed Data
As of 3:59pm ET
 +0.0201 / +1.75%
Today’s Change
0.71
Today|||52-Week Range
1.42
+27.17%
Year-to-Date
No recent news for BioLine RX Ltd.

Today’s Trading

Previous close1.15
Today’s open1.17
Day’s range1.15 - 1.19
Volume346,234
Average volume (3 months)351,530
Market cap$68.1M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+16.35%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
OVASOvaScience Inc-0.01-0.52%
TTNPTitan Pharmaceutical...+0.15+4.69%
TCONTRACON Pharmaceutica...+0.05+1.19%
GNMXAevi Genomic Medicin...+0.08+4.32%
Data as of 3:59pm ET, 03/28/2017

Financials

Next reporting dateMay 23, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Head-Investor Relations
Philip Adam Serlin
Chief Financial Officer
Mali Zeevi
Corporate headquarters
Modi'in, Tel Aviv

Forecasts